NICE (UK) negative for Opzelura (ruxolitinib cream) for treating non-segmental vitiligo in people 12 years and over – Incyte
NICE (UK): Ruxolitinib cream is not recommended, within its marketing authorisation, for treating non-segmental vitiligo with facial involvement in people 12 years and over. This recommendation is not intended… read more.
